IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Rises on Strong Licensing Performance Lantheus Holdings LNTH Q1 2026 Earnings EPS Surges Past Estimates as Radiopharmaceutical Momentum Continues PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints Ultragenyx Q1 2026 Earnings WiderThanExpected Loss as No Revenue Reported OPAD Q1 2026 Earnings Narrower Loss Beats Estimates Stock Jumps QMCO Q1 2026 Earnings EPS Beats Estimates by 216 Stock Gains